NCT07718737
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07718737
Title Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Multitude Therapeutics Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Hematology Oncology Associates of the Treasure Coast NOT_YET_RECRUITING Port Saint Lucie Florida 34952 United States Details
Lumi Research NOT_YET_RECRUITING Kingwood Texas 77339 United States Details
Coffs Harbour Health Campus NOT_YET_RECRUITING Coffs Harbour Australia Details
Austin Health (Olivia Newton John Cancer Centre) NOT_YET_RECRUITING Melbourne Australia Details
St Vincent's Hospital Melbourne NOT_YET_RECRUITING Melbourne Australia Details
Calvary Mater Newcastle NOT_YET_RECRUITING Newcastle Australia Details
Macquarie University Hospital RECRUITING Sydney Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field